During the past decade, Joint and Muscle Research Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 15 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Joint and Muscle Research Institute" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "Amgen" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joint and Muscle Research Institute" #1 collaborator was "Galapagos NV" with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Joint and Muscle Research Institute" are "Systemic Lupus Erythematosus" (8 trials), "Rheumatoid Arthritis" (4 trials), "Lupus Erythematosus, Systemic" (2 trials), "Psoriatic Arthritis" (2 trials) and "Active Cutaneous Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Joint and Muscle Research Institute" in a lesser frequency.

Most popular intervention types in "Joint and Muscle Research Institute" are "Drug" (23 trials), "Other" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Filgotinib" (4 trials), "Baricitinib" (3 trials), "Placebo to match filgotinib" (3 trials) and "Tocilizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Joint and Muscle Research Institute" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Joint and Muscle Research Institute". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Joint and Muscle Research Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Joint and Muscle Research Institute, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".